Free Trial

Impact Investors Inc Invests $763,000 in IMAX Co. (NYSE:IMAX)

IMAX logo with Consumer Discretionary background
Remove Ads

Impact Investors Inc bought a new position in shares of IMAX Co. (NYSE:IMAX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 29,793 shares of the company's stock, valued at approximately $763,000. Impact Investors Inc owned approximately 0.06% of IMAX as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of IMAX. Blue Trust Inc. boosted its stake in IMAX by 138.5% during the fourth quarter. Blue Trust Inc. now owns 966 shares of the company's stock worth $25,000 after acquiring an additional 561 shares in the last quarter. Huntington National Bank bought a new position in shares of IMAX in the third quarter valued at $34,000. Quarry LP lifted its stake in shares of IMAX by 78,333.3% in the third quarter. Quarry LP now owns 2,353 shares of the company's stock valued at $48,000 after buying an additional 2,350 shares in the last quarter. US Bancorp DE lifted its stake in shares of IMAX by 23.4% in the third quarter. US Bancorp DE now owns 7,656 shares of the company's stock valued at $157,000 after buying an additional 1,452 shares in the last quarter. Finally, Intech Investment Management LLC bought a new position in shares of IMAX in the third quarter valued at $205,000. 93.51% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on IMAX. Barrington Research raised their price objective on shares of IMAX from $30.00 to $32.00 and gave the company an "outperform" rating in a research note on Thursday, February 20th. StockNews.com lowered shares of IMAX from a "buy" rating to a "hold" rating in a research note on Thursday, February 13th. Benchmark reaffirmed a "buy" rating and issued a $30.00 price objective on shares of IMAX in a research note on Thursday, February 20th. Macquarie raised their price target on shares of IMAX from $28.00 to $30.00 and gave the company an "outperform" rating in a research report on Thursday, February 20th. Finally, Wells Fargo & Company raised their price target on shares of IMAX from $26.00 to $32.00 and gave the company an "overweight" rating in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $30.67.

Remove Ads

Read Our Latest Analysis on IMAX

IMAX Stock Up 0.9 %

NYSE IMAX traded up $0.24 during trading hours on Friday, reaching $25.59. 562,788 shares of the company were exchanged, compared to its average volume of 725,041. IMAX Co. has a 1 year low of $14.94 and a 1 year high of $27.77. The business's 50 day simple moving average is $24.74 and its 200-day simple moving average is $23.19. The stock has a market capitalization of $1.36 billion, a P/E ratio of 52.23, a P/E/G ratio of 1.49 and a beta of 1.22.

IMAX (NYSE:IMAX - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.31 by ($0.14). IMAX had a return on equity of 8.60% and a net margin of 7.40%. The company had revenue of $92.67 million for the quarter, compared to analysts' expectations of $104.08 million. As a group, sell-side analysts anticipate that IMAX Co. will post 0.91 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Kenneth Ian Weissman sold 6,309 shares of the firm's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $25.51, for a total transaction of $160,942.59. Following the completion of the sale, the insider now owns 25,139 shares in the company, valued at approximately $641,295.89. This trade represents a 20.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert D. Lister sold 55,910 shares of the firm's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $25.50, for a total transaction of $1,425,705.00. Following the sale, the executive vice president now owns 138,889 shares of the company's stock, valued at $3,541,669.50. This trade represents a 28.70 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 65,176 shares of company stock worth $1,662,110. Insiders own 24.08% of the company's stock.

IMAX Profile

(Free Report)

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.

Recommended Stories

Institutional Ownership by Quarter for IMAX (NYSE:IMAX)

Should You Invest $1,000 in IMAX Right Now?

Before you consider IMAX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.

While IMAX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads